Nobelpharma
This article was originally published in The Gray Sheet
Executive Summary
Will appeal jury verdict on litigation involving Implant Innovations, Inc. (3i) that it fraudulently obtained a patent regarding surface technology on titanium dental implants ("The Gray Sheet" May 16, I&W-9). Nobelpharma "strongly believes that the verdict is wrong, and that it is the result of erroneous rulings made by the Court, including rulings that precluded several of Nobelpharma's witnesses from testifying." The firm notes that in January 1989 Core-Vent signed a consent decree asserting the validity of the same patent at issue in the 3i case. Additional litigation is ongoing between Core-Vent and Nobelpharma, Core-Vent says...